You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HLA DR3-DQ2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 1, Autoimmune Diseases, Prevention Trial in Malmö (Diamyd)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • +2 more
  • Malmö, Sweden
    Lund University/CRC, Skåne University Hospital,
Jan 4, 2023

Health Status of Children Born After Assisted Reproductive

Recruiting
  • Children Born After Assisted Reproductive Technologies
  • +2 more
  • hemogram examination
  • Almaty, Kazakhstan
    Sevara ilmuratova
Oct 17, 2023

Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute

Recruiting
  • Acute Rejection of Renal Transplant
  • Graft Failure
  • Donor-derived cell-free DNA
  • Loma Linda, California
    Loma Linda University Health
Jul 19, 2022

Ovarian Cancer Trial (Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in

Not yet recruiting
  • Ovarian Cancer
  • Autologous genetically modified ADP-A2M4CD8 cells
  • Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab
  • (no location specified)
Jan 31, 2023

Trifecta-Lung cfDNA-MMDx Study

Recruiting
  • Lung Transplantation
    • Melbourne, Australia
    • +5 more
    Apr 18, 2023

    Rejection; Transplant, Liver, Liver Failure, Liver Diseases Trial in Cambridge, London (QEL-001)

    Recruiting
    • Rejection; Transplant, Liver
    • +2 more
    • Birmingham, United Kingdom
    • +3 more
    Dec 22, 2022

    Tumors Trial in Worldwide (Letetresgene autoleucel)

    Active, not recruiting
    • Neoplasms
    • Letetresgene autoleucel
    • Pittsburgh, Pennsylvania
    • +5 more
    Aug 7, 2023

    Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Aldesleukin
    • +12 more
    • Los Angeles, California
      USC / Norris Comprehensive Cancer Center
    Aug 9, 2023

    Kidney Transplant Rejection Trial (MDR-102, Immunosuppressive Agents)

    Not yet recruiting
    • Kidney Transplant Rejection
    • MDR-102
    • Immunosuppressive Agents
    • (no location specified)
    Apr 4, 2022

    HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

    Recruiting
    • HLA-A2 Positive Cells Present
    • Refractory Melanoma
    • Alpha-type-1 Polarized Dendritic Cells
    • +5 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Dec 12, 2022

    Hematologic Malignancies Trial in La Jolla (Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant)

    Suspended
    • Hematologic Malignancies
    • Cyclophosphamide 50 mg/kg IV Days 3 and 4 post transplant
    • La Jolla, California
      UCSD Medical Center
    Jul 20, 2022

    Kidney Transplant Trial in Canada, United States (Abatacept, Standard of Care at US Transplant Centers)

    Not yet recruiting
    • Kidney Transplant
    • Abatacept
    • Standard of Care at US Transplant Centers
    • Birmingham, Alabama
    • +19 more
    Jun 20, 2023

    HIV-1-infection Trial in Ghent (Dual versus triple therapy in treatment of HIV-1 infection.)

    Recruiting
    • HIV-1-infection
    • Dual versus triple therapy in treatment of HIV-1 infection.
    • Ghent, Belgium
      Ghent University Hospital
    Dec 5, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +9 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +7 more
    • Duarte, California
    • +1 more
    Sep 22, 2023

    Advanced Cancer, Lymphoma, Solid Tumor Trial in Edinburgh, Newcastle, Oxford (NUC-7738)

    Recruiting
    • Advanced Cancer
    • +2 more
    • Edinburgh, United Kingdom
    • +2 more
    Dec 7, 2022

    Glioblastoma Multiforme of Brain Trial in Tübingen (Multipeptide plus XS15)

    Recruiting
    • Glioblastoma Multiforme of Brain
    • Multipeptide plus XS15
    • Tübingen, BW, Germany
      University Hospital Tübingen
    May 9, 2022

    Oral Upadacitinib Tablets to Assess Change in Disease Symptoms

    Recruiting
    • Rheumatoid Arthritis (RA)
      • Edmonton, Alberta, Canada
      • +38 more
      Jan 17, 2023

      Diabetes, Type 1 Trial in Linköping (GAD-alum (Diamyd) 40 µg/mL)

      Recruiting
      • Diabetes Mellitus, Type 1
      • GAD-alum (Diamyd) 40 μg/mL
      • Linköping, Sweden
        Kliniska Forskningsenheten (Hudmottagningen), Universitetssjukhu
      Aug 17, 2022

      Advanced Melanoma Trial (Tebentafusp, Tebentafusp with Pembrolizumab, Investigators Choice)

      Not yet recruiting
      • Advanced Melanoma
      • (no location specified)
      Sep 19, 2022

      Coronary Artery Disease Trial in Sudbury (Atorvastatin)

      Terminated
      • Coronary Artery Disease
      • Sudbury, Ontario, Canada
      • +2 more
      May 27, 2022

      Development of Antibodies Against Transplant Kidney After

      Completed
      • Acute Infection
      • Kidney Failure
      • Level of antibodies
      • Ostrava, Moravian-Silesian Region, Czechia
        University Hospital Ostrava
      Sep 8, 2023

      Celiac Disease in Children, Autoimmune Diseases, type1diabetes Trial in Malmö (Gluten reduced diet)

      Recruiting
      • Celiac Disease in Children
      • +2 more
      • Gluten reduced diet
      • Malmö, Sweden
        Clinical Research Center (CRC), Bldng 60:11
      Aug 30, 2022

      Kidney Transplant Rejection Trial in Canada, United States (MDR-101)

      Active, not recruiting
      • Kidney Transplant Rejection
      • MDR-101
      • La Jolla, California
      • +19 more
      Aug 22, 2022

      Select Advanced Solid Tumors Trial in Canada, United Kingdom, United States (IMCnyeso)

      Terminated
      Has Results
      • Select Advanced Solid Tumors
      • Aurora, Colorado
      • +11 more
      Mar 9, 2022

      Study of Eplets Matching in Kidney Transplantation

      Active, not recruiting
      • Kidney Transplantation
      • Eplets mismatching numbers
      • Xi'an, Shaanxi, China
        The First Affiliated Hospital of Xi'an Jiaotong University
      May 25, 2022